THE STABILIZATION OF A HUMAN-IGM MONOCLONAL-ANTIBODY WITH POLY(VINYLPYRROLIDONE)

被引:49
|
作者
GOMBOTZ, WR
PANKEY, SC
PHAN, D
DRAGER, R
DONALDSON, K
ANTONSEN, KP
HOFFMAN, AS
RAFF, HV
机构
[1] BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,BIOL PROC RES,SEATTLE,WA 98121
[2] MILES INC,CUTTER BIOL,BERKELEY,CA 94701
[3] UNIV WASHINGTON,CTR BIOENGN FL 20,SEATTLE,WA 98195
关键词
PROTEIN STABILITY; PROTEIN AGGREGATION; MONOCLONAL ANTIBODIES; VOLUME EXCLUSION; POLY(VINYLPYRROLIDONE);
D O I
10.1023/A:1018903624373
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
An IgM anti-group B Streptococcus monoclonal antibody (4B9) was found to undergo irreversible heat-induced aggregation at 50 degrees C. A variety of excipients was tested for their ability to inhibit antibody aggregation. The amount of 4B9 aggregation, which was determined by analysis on a size-exclusion HPLC, was significantly reduced in the presence of low concentrations [between 0.1 and 1.0% (w/v)] of poly(vinylpyrrolidone) (PVP) molecules ranging in molecular weight from 10 to 40 kDa. When the PVP concentration was greater than 1.05%, antibody aggregation was enhanced, and with the highest molecular weight PVP, antibody precipitation occurred. HPLC was used to show that more PVP was associated with the 4B9 at 50 degrees C than at 25 degrees C. Differential scanning calorimetry revealed that PVP concentrations greater than 2.0% decreased the antibody thermal transition temperature. Enzyme-linked immunosorbent assays were used to assess the effects of PVP on the antigen binding capacity of 4B9 and on 4B9 quantitation. At 4 degrees C, PVP solutions of up to 5.0% had no effect on either 4B9 quantitation or antigen binding. At 50 degrees C, however, less 4B9 was detected in the 5.0% PVP solution. The heat stabilization of the 4B9 antibody by low concentrations of PVP can be explained by a weak binding of PVP to the native protein. The PVP may sterically interfere with protein-protein interactions, thus reducing aggregation. Higher concentrations of PVP lead to protein aggregation and precipitation, probably by a volume-exclusion mechanism. Low concentrations of less than 1.0% PVP can be used to stabilize proteins against heat-induced aggregation, but care should be exercised, since even slightly higher concentrations of PVP can also lead to protein destabilization.
引用
收藏
页码:624 / 632
页数:9
相关论文
共 50 条
  • [1] HUMAN-IGM MONOCLONAL-ANTIBODY 16.88 - PHARMACOKINETICS AND DISTRIBUTION IN MOUSE AND MAN
    HAISMA, HJ
    KESSEL, MAP
    SILVA, C
    VANMUIJEN, M
    ROOS, JC
    BRIL, H
    MARTENS, HJM
    MCCABE, R
    BOVEN, E
    BRITISH JOURNAL OF CANCER, 1990, 62 : 40 - 43
  • [2] TREATMENT OF EXPERIMENTAL PSEUDOMONAS-AERUGINOSA PNEUMONIA WITH A HUMAN-IGM MONOCLONAL-ANTIBODY
    HECTOR, RF
    COLLINS, MS
    PENNINGTON, JE
    JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (03): : 483 - 489
  • [3] PHASE-I TRIAL AND PHARMACOKINETICS OF A HUMAN-IGM MONOCLONAL-ANTIBODY TO ENDOTOXIN (LPS)
    KHAZAELI, M
    KUBAGAWA, H
    TENG, N
    ZIEGLER, E
    ROGERS, K
    PETERSON, L
    SALEH, M
    BOGARD, C
    CARRANO, R
    BERGER, H
    LOBUGLIO, A
    CLINICAL RESEARCH, 1987, 35 (03): : A615 - A615
  • [4] EVALUATION OF PRODUCT EQUIVALENCE DURING PROCESS OPTIMIZATION FOR MANUFACTURE OF A HUMAN-IGM MONOCLONAL-ANTIBODY
    MAIORELLA, BL
    FERRIS, R
    THOMSON, J
    WHITE, C
    BRANNON, M
    HORA, M
    HENRIKSSON, T
    TRIGLIA, R
    KUNITANI, M
    KRESIN, L
    DOLLINGER, G
    JONES, R
    SENYK, G
    YOUNG, J
    MOYER, B
    MCENTIRE, J
    DOUGHERTY, J
    MONICA, T
    GOOCHEE, C
    BIOLOGICALS, 1993, 21 (03) : 197 - 205
  • [5] QUANTIFICATION OF MONOCLONAL HUMAN-IGM
    KLEIN, F
    DEBRUIJN, AM
    KORNMANVANDENBOSCH, HJ
    CLINICAL CHEMISTRY, 1985, 31 (02) : 353 - 353
  • [6] A MONOCLONAL-ANTIBODY TO THE HEAVY-CHAIN OF HUMAN-IGM WITH A PARTICULAR REACTION PATTERN IN HUMAN B-CELL MALIGNANCIES
    HENKE, M
    SANTOS, S
    WINBERG, CD
    SHIVELY, JE
    BLUT, 1987, 55 (03): : 173 - 179
  • [7] A NONNEUTRALIZING HUMAN-IGM MONOCLONAL-ANTIBODY INHIBITING HEMAGGLUTINATION OF H3N2 INFLUENZA-A STRAINS
    CASCINO, I
    BENEDETTO, A
    MAZZILLI, MC
    AMICI, C
    CAMPORIONDO, MP
    TESTA, L
    ZANIRATTI, S
    CHESSA, L
    GANDINI, E
    HYBRIDOMA, 1986, 5 (04): : 307 - 318
  • [8] CROSS-LINKED BISPECIFIC MONOCLONAL-ANTIBODY HETEROPOLYMERS FACILITATE THE CLEARANCE OF HUMAN-IGM FROM THE CIRCULATION OF SQUIRREL-MONKEYS
    REIST, CJ
    LIANG, HY
    DENNY, D
    MARTIN, EN
    SCHELD, WM
    TAYLOR, RP
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (09) : 2018 - 2025
  • [9] HUMAN-IGM ANTIBODY TO VIMENTIN INTERMEDIATE FILAMENTS
    SENECAL, JL
    RUDERMAN, M
    ROTHFIELD, NF
    OLIVER, JM
    CLINICAL RESEARCH, 1982, 30 (02): : A656 - A656
  • [10] HUMAN-IGM MONOCLONAL ANTI-GD2 ANTIBODY - REACTIVITY TO A HUMAN-MELANOMA XENOGRAFT
    KATANO, M
    SAXTON, RE
    TSUCHIDA, T
    IRIE, RF
    JAPANESE JOURNAL OF CANCER RESEARCH, 1986, 77 (06): : 584 - 594